March 30, 2017
Controversial changes to drug patent and copyright rules required under Canada’s recent trade deals will have manageable side effects, according to a new report from the C.D. Howe Institute. In “Patents, Copyright and Competition: Assessing the Impact of Trade Deals on Canada,” authors Daniel Schwanen and Aaron Jacobs review claims that strengthened protection for patents and copyright would result in a dramatic increase in healthcare costs as well as copyright payments, and provide some estimates of their own.
